Quantitative determination of perifosine, a novel alkylphosphocholine anticancer agent, in human plasma by reversed-phase liquid chromatography–electrospray mass spectrometry
- 1 August 2001
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 759 (2) , 247-257
- https://doi.org/10.1016/s0378-4347(01)00231-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Quantitation of cerivastatin and its seven acid and lactone biotransformation products in human serum by liquid chromatography–electrospray tandem mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Human urinary bladder carcinoma cell lines respond to treatment with alkylphosphocholinesCancer Letters, 1999
- Quantification of perifosine, an alkylphosphocholine anti-tumour agent, in plasma by pneumatically assisted electrospray tandem mass spectrometry coupled with high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Cytotoxic Etherphospholipid AnaloguesGeneral Pharmacology: The Vascular System, 1998
- Alkylphosphocholines induce apoptosis in HL-60 and U-937 leukemic cellsCancer Chemotherapy and Pharmacology, 1997
- Cellular signalling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transductionAdvances in Enzyme Regulation, 1996
- Capillary Gas Chromatography of Hexadecylphosphocholine in Caco-2T Cells and Cell Culture MediaAnalytical Biochemistry, 1995
- Phase II Trial of Orally Administered Miltefosine in Advanced Colorectal CancerOncology Research and Treatment, 1993
- Daily Oral Miltefosine (Hexadecylphosphocholine) in Patients with Advanced Breast Cancer: A Phase II StudyOncology Research and Treatment, 1993
- Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatmentCancer Chemotherapy and Pharmacology, 1992